Skip to main content
. 2008 Jun 24;131(8):2094–2105. doi: 10.1093/brain/awn112

Table 1.

Demographic and drug details of PD Patients and controls

No Sex Age Sw- En HY Off HY On UPDRS Off UPDRS On Years (diagnosis) L-dopa mg/d L-dopa equivalent1 Nart error Predicted FullScale IQ MM SE Fluency
Medications (mg)
P Animals A C R E Other
1 F 53 80 2 2 24 14 8.7 900 2200 6 123 30 20 28 100 21
2 M 61 70 4 2 53 17 15.4 2200 2585 5 124 30 24 24 300 T 300
3 M 78 80 4 3 50 30 13.5 700 512 29 104 25 13 20 O 120
4 F 65 100 2 2 12 7 5.0 250 1090 30 103 30 17 24 21 O 50, D 30
5 M 65 70 2.5 2.5 36 19 13.5 700 1196 36 98 27 22 25 800 S 10
6 F 50 90 2.5 2 34 15 9.5 300 1200 27 105 27 11 19 200 15
7 F 78 90 2 1 14 1 5.7 600 600 28 105 29 12 17
8 M 64 90 2 2 20 17 3.0 400 1290 5 124 30 19 28 100 P 2.1
9 M 69 80 2 2 29 18 4.8 400 1120 45 91 29 10 19 4 S 1.25
10 F 65 90 3 2.5 38 30 4.6 600 1560 32 101 27 6 20 24
11 M 59 80 2.5 2 36 29 5.7 500 1140 13 117 30 23 24 200 4
12 F 59 70 2.5 2 34 31 5.5 300 1260 12 118 30 31 35 6
13 M 68 80 2.5 2 32 20 9.0 250 915 33 100 28 9 11 4 S 5
14 M 66 80 2.5 2 33 25 6.9 800 1009 37 97 26 11 16 200 1 600
15 F 75 80 2.5 2 34 26 10.7 1200 1745 2 127 27 23 17 200 18 800
16 F 62 90 3 1 26 10 5.4 500 1020 42 93 29 21 12 18 600
17 M 62 100 2.5 2 30 19 5.2 800 1640 42 93 28 8 24 100 P 1
18* M 75 70 3 2 32 22 5.6 1300 1475 15 115 26 18 16 9
19** M 63 70 2.5 2 39 14 10.1 600 1680 12 118 29 12 24 200 24 800

Patients
11m Mean 65.1 82.1 2.6 2.0 31.9 19.2 7.8 700.0 1328.3 23.7 108.2 28.3 16.3 21.2
8 f SD 7.7 9.8 0.4 0.5 10.2 8.2 3.5 467.6 502.7 14.2 11.9 1.6 6.7 5.9

Controls
8 m Mean 67.4 14 116 29.1 16.1 21.8
9 f SD 6.1 7.2 6 0.8 4.6 5

1Equivalent levodopa dose = [levodopa (× 1.2 if COMT inhibitor)(× 1.2 if 10 mg of S or × 1.1 if 5 mg of S)] + [P × 400] + [R × 40] + [C × 160] + [pergolide × 200] + [bromocriptine × 10] + [lisuride × 160]; all doses are in milligrams. [Williams Gray C. J Neurosci 2007 27 4832–38]. *arachnoid cyst, excluded from imaging analysis, SwEn = Schwab and England; H Y = Hoehn and Yahr; UDPRS = Unified Parkinson's Disease Rating Scale motor subscale III; MMSE = Folstein Mini-Mental State Examination; NART = national adult reading test estimate of premorbid IQ. **dyskinetic ‘on’, excluded from imaging analysis. Other drugs as mg/day are: A = amantadine; C = Cabergoline; R = Ropinirole; E = entacapone; T = tolcapone; S = selegiline; P = pramipexole; O = orphenadrine, D = domperidone.